Are spinal GABAergic elements related to the manifestation of neuropathic pain in rat?
Impairment in spinal inhibition caused by quantitative alteration of GABAergic elements following peripheral nerve injury has been postulated to mediate neuropathic pain. In the present study, we tested whether neuropathic pain could be induced or reversed by pharmacologically modulating spinal GABAergic activity, and whether quantitative alteration of spinal GABAergic elements after peripheral nerve injury was related to the impairment of GABAergic inhibition or neuropathic pain. To these aims, we first analyzed the pain behaviors following the spinal administration of GABA antagonists (1 microg bicuculline/rat and 5 microg phaclofen/rat), agonists (1 microg muscimol/rat and 0.5 microg baclofen/rat) or GABA transporter (GAT) inhibitors (20 microg NNC-711/rat and 1 microg SNAP-5114/rat) into naïve or neuropathic animals. Then, using Western blotting, PCR or immunohistochemistry, we compared the quantities of spinal GABA, its synthesizing enzymes (GAD65, 67) and its receptors (GABA(A) and GABA(B)) and transporters (GAT-1, and -3) between two groups of rats with different severity of neuropathic pain following partial injury of tail-innervating nerves; the allodynic and non-allodynic groups. Intrathecal administration of GABA antagonists markedly lowered tail-withdrawal threshold in naïve animals, and GABA agonists or GAT inhibitors significantly attenuated neuropathic pain in nerve-injured animals. However, any quantitative changes in spinal GABAergic elements were not observed in both the allodynic and non-allodynic groups. These results suggest that although the impairment in spinal GABAergic inhibition may play a role in mediation of neuropathic pain, it is not accomplished by the quantitative change in spinal elements for GABAergic inhibition and therefore these elements are not related to the generation of neuropathic pain following peripheral nerve injury.
Lee
Jaehee
J
Medical Science Research Center and Department of Physiology, Korea University College of Medicine, Seoul 136-705, Korea.
Back
Seung Keun
SK
Lim
Eun Jeong
EJ
Cho
Gyu Chong
GC
Kim
Myung Ah
MA
Kim
Hee Jin
HJ
Lee
Min Hee
MH
Na
Heung Sik
HS
J Neurochem. 1991 Feb;56(2):720-3
1988566
J Neurosci. 2005 Jul 13;25(28):6658-66
16014727
J Neurosci Methods. 1994 Jul;53(1):55-63
7990513
Exp Neurol. 1990 Sep;109(3):273-8
2170161
Brain Res. 1993 Aug 27;620(2):287-91
8369960
Neuroscience. 1997 Feb;76(3):845-58
9135056
Brain Res. 1995 May 15;679(2):289-97
7633890
Pain. 1981 Apr;10(2):187-197
7267135
Pain. 2004 Jun;109(3):379-388
15157699
Med Hist. 1967 Jan;11(1):97-9
5341040
J Comp Neurol. 1996 Feb 12;365(3):392-412
8822178
Neuropharmacology. 1994 Sep;33(9):1103-8
7838323
Nature. 2003 Aug 21;424(6951):938-42
12931188
Neuron. 1993 Feb;10(2):165-75
7679913
Neurosci Lett. 2002 May 3;323(3):171-4
11959412
J Neurosci. 1988 Jun;8(6):2123-30
3385490
Pain. 2001 May;92(1-2):29-40
11323124
Exp Brain Res. 1998 Jan;118(2):259-68
9547096
J Chem Neuroanat. 1998 Dec;16(1):57-72
9924973
Neuroreport. 2003 Aug 26;14(12):1623-6
14502088
Neuroscience. 2006;138(4):1277-87
16427742
Anesthesiology. 2001 Feb;94(2):333-9
11176099
Pain. 2006 Jul;123(1-2):117-26
16564625
Anesthesiology. 2002 May;96(5):1161-7
11981157
Eur J Pharmacol. 2001 Oct 19;429(1-3):23-37
11698024
Pain. 2004 Sep;111(1-2):144-50
15327818
Brain Res. 1996 Jul 22;728(1):27-36
8864294
J Auton Nerv Syst. 1983 Mar-Apr;7(3-4):399-411
6875197
J Comp Neurol. 2001 Jul 2;435(3):276-82
11406811
Pain. 1997 Mar;70(1):15-22
9106805
Pain. 1989 Apr;37(1):111-123
2542867
Neuroreport. 2001 Jan 22;12(1):175-8
11201082
Pain. 2003 Sep;105(1-2):347-53
14499453
J Neurosci Res. 2003 Aug 15;73(4):565-72
12898541
Pain. 2003 Jul;104(1-2):229-39
12855333
J Neurosci. 2002 Aug 1;22(15):6724-31
12151551
Neurosci Lett. 1994 Dec 5;182(2):299-302
7715832
Pain. 2001 Feb 15;90(3):217-226
11207393
J Neurophysiol. 1994 Jul;72(1):169-79
7965003
Neuron. 1993 Feb;10(2):177-88
7679914